Showing results (401-410 of 452) with videos related to

Sort By:
Pageof 46
Journal of Clinical Medicine|January 11, 2025
Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic AsthmaFrancesco Menzella, Mariarita Marchi, Marco Caminati, et al.
Respiratory Medicine|September 12, 2020
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposisDiego Bagnasco, Luisa Brussino, Marco Bonavia, et al.
Clinical and Molecular Allergy : CMA|June 24, 2015
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderlyNicola Scichilone, Maria T Ventura, Matteo Bonini, et al.
Journal of Personalized Medicine|February 25, 2025
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to OmalizumabDiego Bagnasco, Benedetta Bondi, Luisa Brussino, et al.
Journal of Personalized Medicine|August 29, 2024
RIAIT (Italian Registry of Allergen Immunotherapy): Protocol for a New Tool in a New Vision of Disease-Modifying Therapy for AllergistsGiovanni Costanzo, Cristiano Caruso, Giovanni Paoletti, et al.
Respiration; International Review of Thoracic Diseases|March 28, 2018
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary FibrosisSergio Harari, Antonella Caminati, Venerino Poletti, et al.
The World Allergy Organization Journal|August 19, 2024
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approachMarco Caminati, Lucia Federica Carpagnano, Chiara Alberti, et al.
The World Allergy Organization Journal|January 26, 2026
Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE studyGiorgio Walter Canonica, Gianenrico Senna, Luisa Brussino, et al.
Journal of Personalized Medicine|November 25, 2023
Chronic Rhinosinusitis with Nasal Polyps: A Survey on Routine Management and Evaluation of Disease Control in PracticeEugenio De Corso, Giancarlo Ottaviano, Carlotta Pipolo, et al.
ERJ Open Research|February 18, 2026
Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a post hoc analysis of the ANANKE studyGianenrico Senna, Luisa Brussino, Maria Aliani, et al.
Pageof 46